These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28970455)

  • 21. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries.
    Svensberg K; Sporrong SK; Björnsdottir I
    Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe.
    Minghetti P; Pantano D; Gennari CG; Casiraghi A
    Health Policy; 2014 Sep; 117(3):328-33. PubMed ID: 25110297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
    Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
    BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists.
    Merks P; Swieczkowski D; Byliniak M; Drozd M; Krupa K; Jaguszewski M; Brindley DA; Naughton BD
    Eur J Hosp Pharm; 2018 Jan; 25(1):10-15. PubMed ID: 29445453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Promotion of Pharmaceutical Care and Sciences: Focus of the Japanese Society of Pharmaceutical Health Care and Sciences].
    Sasaki H
    Yakugaku Zasshi; 2019; 139(3):405-410. PubMed ID: 30828019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The transformation of pharmacy concepts into building and organization.
    Mobach MP
    Pharm World Sci; 2005 Aug; 27(4):329-38. PubMed ID: 16228633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacist-reported practice change as a result of a statewide community pharmacy accreditation program.
    Frey M; Trapskin K; Margolis A; Sutter S; Cory P; Decker C
    J Am Pharm Assoc (2003); 2019; 59(3):403-409. PubMed ID: 30940517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The development and implementation of pharmaceutical care across borders.
    van den Brink H; Nanthini Haridass I; Siranyan V
    Ann Pharm Fr; 2012 Mar; 70(2):82-7. PubMed ID: 22500959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical care in community pharmacies: practice and research in Peru.
    Alvarez-Risco A; van Mil JW
    Ann Pharmacother; 2007 Dec; 41(12):2032-7. PubMed ID: 17940126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence-based pharmaceutical care: The next chapter in pharmacy practice.
    Al-Quteimat OM; Amer AM
    Saudi Pharm J; 2016 Jul; 24(4):447-51. PubMed ID: 27330375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migraine management in community pharmacies: practice patterns and knowledge of pharmacy personnel in Thailand.
    Saengcharoen W; Lerkiatbundit S
    Headache; 2013 Oct; 53(9):1451-63. PubMed ID: 23808927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality pharmacy services and key performance indicators in Polish NICUs: a Delphi approach.
    Krzyżaniak N; Pawłowska I; Bajorek B
    Int J Clin Pharm; 2018 Jun; 40(3):533-542. PubMed ID: 29605949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Governance and the pharmaceutical workforce in England.
    Noyce P
    Res Social Adm Pharm; 2006 Sep; 2(3):408-19. PubMed ID: 17138523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical care, European developments in concepts, implementation, teaching, and research: a review.
    van Mil JW; Schulz M; Tromp TF
    Pharm World Sci; 2004 Dec; 26(6):303-11. PubMed ID: 15683098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a strategic model for integrating complementary medicines into professional pharmacy practice.
    Ung COL; Harnett J; Hu H
    Res Social Adm Pharm; 2018 Jul; 14(7):663-672. PubMed ID: 28784591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary health care policy and vision for community pharmacy and pharmacists in Australia.
    Dineen-Griffin S; Benrimoj SI; Garcia-Cardenas V
    Pharm Pract (Granada); 2020; 18(2):1967. PubMed ID: 32477437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Legislation on the preparation of medicinal products in European pharmacies and the Council of Europe Resolution.
    Scheepers HP; Langedijk J; Neerup Handlos V; Walser S; Schutjens MH; Neef C
    Eur J Hosp Pharm; 2017 Jul; 24(4):224-229. PubMed ID: 31157801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical care in community pharmacies: practice and research in Brazil.
    de Castro MS; Correr CJ
    Ann Pharmacother; 2007 Sep; 41(9):1486-93. PubMed ID: 17666581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community pharmacy practice in Japan--results of a survey.
    Iguchi S; Ohnishi M; Nishiyama T; Hosono K; Umezawa C
    J Clin Pharm Ther; 1998 Jun; 23(3):223-7. PubMed ID: 9831974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining professional pharmacy services in community pharmacy.
    Moullin JC; Sabater-Hernández D; Fernandez-Llimos F; Benrimoj SI
    Res Social Adm Pharm; 2013; 9(6):989-95. PubMed ID: 23591411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.